This feature articles commemorates the 10-year anniversary of the FDA's first approval of an SGLT2 inhibitor on March 29, 2013 and provides a snapshot at the class's ascent into the treatment algorithms and guidelines for type 2 diabetes, heart failure, and chronic kidney disease.
Proposition 29 would have required dialysis clinics to have a doctor, nurse practitioner or physician assistant present while patients are receiving care.
Proposition 29 would have required dialysis clinics to have a doctor, nurse practitioner or physician assistant present while patients are receiving care.
Proposition 29 would have required dialysis clinics to have a doctor, nurse practitioner or physician assistant present while patients are receiving care.